Sitafor Tablets

Sitafor Tablets – Advanced Glycemic Control for Type 2 Diabetes

Sitafor is a modern hypoglycemic agent used in the management of metabolic health, containing the active ingredient Sitagliptin. It is specifically indicated for the treatment of type 2 diabetes mellitus in adult patients. As a selective DPP-4 inhibitor, Sitafor works by increasing the levels of natural hormones called incretins. These hormones help the body regulate its blood sugar by stimulating the pancreas to release more insulin when needed and signaling the liver to stop producing excess sugar. This dual action helps maintain stable glucose levels throughout the day and is particularly effective after meals. Sitafor is typically used as part of a comprehensive management plan that includes dietary modifications and regular physical activity. It is well-regarded for its established safety profile and a lower risk of causing hypoglycemia compared to some other classes of diabetes medications. Regular once-daily oral administration provides consistent glycemic control, helping to prevent the serious long-term complications of diabetes such as kidney damage and nerve problems. It is a reliable and well-tolerated choice for maintaining long-term metabolic health and achieving target HbA1c levels in adults.

• Indicated for the treatment of type 2 diabetes mellitus.
• Works as a selective DPP-4 inhibitor to regulate insulin levels.
• Supports stable glycemic control with once-daily oral dosing.
• Available as: Tablets 50mg and 100mg.